STOCK TITAN

Sale of 20,000 Cohen & Steers (NYSE: CNS) shares planned under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of Cohen & Steers, Inc. filed a Rule 144 notice to sell 20,000 shares of common stock through Charles Schwab & Co., Inc. on or about February 11, 2026 on the NYSE, with an aggregate market value of $1,310,000. The filing notes that 51,007,541 shares of this class were outstanding. These shares were originally acquired on January 31, 2019 via a restricted stock lapse treated as equity compensation from Cohen & Steers, Inc. The signer represents they are unaware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for CNS disclose?

The Form 144 discloses a planned sale of 20,000 CNS common shares. A Cohen & Steers, Inc. shareholder intends to sell these shares on or about February 11, 2026 on the NYSE, with an aggregate market value of $1,310,000 under Rule 144.

How many Cohen & Steers (CNS) shares are planned to be sold?

The filing covers a proposed sale of 20,000 common shares of CNS. These shares are to be sold through Charles Schwab & Co., Inc., with the notice indicating an approximate aggregate market value of $1,310,000 for the transaction.

When were the CNS shares in the Form 144 originally acquired?

The 20,000 CNS shares were acquired on January 31, 2019. They were received through a restricted stock lapse characterized as equity compensation from Cohen & Steers, Inc., with the acquisition date and payment date both listed as January 31, 2019.

What is the approximate sale date in the CNS Form 144 filing?

The approximate sale date stated is February 11, 2026. The shareholder indicates an intention to sell 20,000 common shares of Cohen & Steers, Inc. on or around that date on the New York Stock Exchange through Charles Schwab & Co., Inc.

How many Cohen & Steers (CNS) shares are outstanding according to this notice?

The notice states that 51,007,541 CNS common shares are outstanding. This figure provides context for the planned sale of 20,000 shares under Rule 144, showing the transaction is small relative to the total outstanding share count.

What representation does the seller make in the CNS Form 144?

The seller represents they know no undisclosed material adverse information. By signing the notice, they state they are unaware of material adverse information about Cohen & Steers’ current or prospective operations that has not already been publicly disclosed.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Latest News

CNS Latest SEC Filings

CNS Stock Data

3.37B
27.18M
46.02%
60.33%
3.88%
Asset Management
Investment Advice
Link
United States
NEW YORK